Deficiencies in Planning Interventional Trial Registration of COVID-19 in China

Frontiers in Medicine

Youlian Zhou¹  Yiling Zhou¹  Sheyu Li²  Xiaodan Li³  Ying Liu⁴  Shengzhao Zhang⁵  Na Su⁵ 

[1] Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China;Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, China;Department of Guideline and Rapid Recommendation, Cochrane China Center, MAGIC China Center, Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, China;Department of Gastroenterology, West China Hospital, Sichuan University, Chengdu, China;Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China;Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, China;West China School of Pharmacy, Sichuan University, Chengdu, China;

关键词: COVID-19;    SARS-CoV-2;    interventional trials;    registries;    China;    sample size index;   

DOI  :  10.3389/fmed.2021.618185

来源: Frontiers

【 授权许可】

CC BY